BVF Inc’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

BVF Inc’s Portfolio PHXM Stock Details PHXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-131,466	Closed	-$690K	–	84
2022 Q3	$690K	Hold	131,466	–	–	0.03%	76
2022 Q2	$1.44M	Hold	131,466	–	–	0.07%	70
2022 Q1	$2.39M	Hold	131,466	–	–	0.1%	72
2021 Q4	$3.1M	Hold	131,466	–	–	0.11%	74
2021 Q3	$7.59M	Hold	131,466	–	–	0.3%	62
2021 Q2	$6.38M	Buy	131,466 +68,966	+110%	+$4.26M	0.24%	58
2021 Q1	$4.47M	Hold	62,500	–	–	0.17%	61
2020 Q4	$6.12M	Hold	62,500	–	–	0.24%	51
2020 Q3	$3.91M	Hold	62,500	–	–	0.21%	56
2020 Q2	$5.26M	Hold	62,500	–	–	0.32%	47
2020 Q1	$3.34M	Hold	62,500	–	–	0.31%	45
2019 Q4	$4.55M	Hold	62,500	–	–	0.35%	41
2019 Q3	$2.77M	Hold	62,500	–	–	0.29%	51
2019 Q2	$4.48M	Hold	62,500	–	–	0.49%	45
2019 Q1	$4.75M	Hold	62,500	–	–	0.53%	42
2018 Q4	$4.23M	Hold	62,500	–	–	0.55%	41
2018 Q3	$5.45M	Hold	62,500	–	–	0.48%	46
2018 Q2	$7.21M	Hold	62,500	–	–	0.7%	37
2018 Q1	$13.1M	Hold	62,500	–	–	1.33%	23
2017 Q4	$13.8M	Buy	+62,500	New	+$14.8M	1.66%	19

Other funds holding PHXM

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

VPIM

Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

BVF Inc's PHXM Position: Q4 2022 in Review

BVF Inc sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q4 2022, closing a stake of 131,466 shares — an estimated $690K sold.

BVF Inc first reported a position in PHXM in Q4 2017 and held it in 20 quarters. The position peaked at $13.8M in Q4 2017. 8 funds tracked by Wall St. Rank hold PHXM as of Q4 2022.

BVF Inc reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q4 2022 after selling out during the quarter.
BVF Inc sold 131,466 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q4 2022, an estimated $690K.
BVF Inc first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2017 and held it in 20 quarters.
BVF Inc's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $13.8M in Q4 2017.
8 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q4 2022.

Based on BVF Inc's 13F filing for Q4 2022, filed 14 Feb 2023.